You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion, look for clinical trials, and connect with others living with it — all in one place.
Open the full Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion hub →Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion is a rare condition. Also known as Von Recklinghausen disease due to NF1 mutation or intragenic deletion. Tomeko brings together the specialists, research, clinical trials, treatments and community for Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:363700 · OMIM 162200 · ICD-10 Q85.0 · GARD 0017570
Start by learning the basics from an authoritative source, find a specialist or center that sees Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion, filtered to your area.
Tomeko shows live, recruiting studies for Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion from ClinicalTrials.gov on the hub.